Bruening Christoph

Avg. Two Year Performance

(49%) Avg. Purchase Return
(22%) Compound
(11%) Avg. Sale Return
(5%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(2%)(22%)(24%)8%(49%)
Purchase Success Rate1 of 30 of 31 of 32 of 30 of 3
Average Sale Return(48%)(63%)(67%)(193%)(11%)
Sale Success Rate0 of 10 of 10 of 10 of 10 of 1

Callisto Pharmaceuticals, I...

Drugs » Drug Manufacturers - Major

Director:

Holdings: 375.7K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--